Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-13
2005-12-13
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C514S453000, C514S662000
Reexamination Certificate
active
06974814
ABSTRACT:
The present invention relates to pharmacological methods for the prevention or amelioration of sleep-related breathing disorders via administration of agents or combinations of agents that possess glutamate-related and/or glycine-related pharmacological activity or that modulate the release of glutamate, glycine, or both from nerve terminals with the central nervous system.
REFERENCES:
patent: 5075290 (1991-12-01), Findley et al.
patent: 5182386 (1993-01-01), Albaugh et al.
patent: 5240948 (1993-08-01), Gueremy et al.
patent: 5356934 (1994-10-01), Robertson et al.
patent: 5688826 (1997-11-01), Massey et al.
patent: 5728728 (1998-03-01), Kozachuk
patent: 6121265 (2000-09-01), Treiber et al.
patent: 6124361 (2000-09-01), Chenard
patent: 6136861 (2000-10-01), Chenard
patent: WO 00/51590 (2000-09-01), None
Bennington et al., “Methodology: Scoring and Computerized Methods—Scoring Transitions to REM Sleep in Rats Based on the EEG Phenomena of Pre-REM Sleep: An Improved Analysis of Sleep Structure,”Sleep,17:28-36 (1994).
Botez et al., “Can We Treat Respiratory Failure in Friedreich Ataxia?”Archives of Neurology,54(8):1030-1033 (1997).
Chamberlin et al., “A Brainstem Network Mediating Apneic Reflexes in the Rat,”J. Neuroscience,18(15):6048-6056 (1998).
Dutschmann et al., “NMDA and GABAAreceptors in the rat Kölliker-Fuse area control cardiorespiratory responses evoked by trigeminal ethmoidal nerve stimulation,”J. Physiol.,510(2):793-804 (1998).
Dutschmann et al., “NMDA- and GABAA-Receptors Relay Trigeminally Induced Apnoea and Cardiac Responses in The Rat Kolliker-Fuse Nucleus,”Society for Neuroscience Abstracts,23(1-2):725 (1997) (Abstract 285.6).
Feldman et al., “Neural Control of Breathing,” In Developmental Neuroscience, Chapter 40, Academic Press, pp. 1063-1090 (1999).
Hedner et al., “A Double-Blind, Randomized Trial of Sabeluzole-A Putative Glutamate Antagonist-in Obstructive Sleep Apnea,”Sleep,19(4):287-9 (1996).
Hudgel et al., “Pharmacologic Treatment of Sleep-disordered Breathing,”American J. Respiratory and Critical Care Medicine,158(3):691-699 (1998).
Hudgel, “Pharmacologic Treatment of Obstructive Sleep Apnea,”J. Lab. Clin. Med.,126:13-18 (1995).
Iber et al., In Chapter VI “Ventilatory Control and Disturbances During Wakefulness and Sleep,” Scientific American, Inc., pp. 1-14 (1997).
Monti et al., “Adenosine Analogues Modulate the Incidence of Sleep Apneas in Rats,”Pharamacol. Biochem. Behav.,51:125-131 (1995).
Carley David W.
Radulovacki Miodrag
Spivack Phyllis G.
The Board of Trustees of the University of Illinois
LandOfFree
Neuropharmacological treatment of sleep-related breathing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuropharmacological treatment of sleep-related breathing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuropharmacological treatment of sleep-related breathing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3465812